Revolutionize Fecal Incontinence Care With Qoramatic® by Consure Medical
Up to 30% of patients admitted to the ICU experience fecal incontinence.¹ Managing fecal incontinence has long been a challenging aspect of healthcare, requiring significant time, effort, and vigilance.
Studies have shown that patients with fecal incontinence are 22 times more likely to develop pressure ulcers compared to those without, exacerbating their vulnerability and complicating recovery.²
FI can also increase the risk of cross-contamination. Pathogens like Clostridioides difficile (C. diff), can spread through contaminated surfaces or healthcare personnel. Such infections contribute to nearly 3 million cases of diarrhea and colitis annually, costing an estimated $6.3 billion in excess medical expenses.³
The Qoramatic® Automated Stool Management Kit is an innovative solution designed to transform stool management with intelligent, proactive technology.
Qoramatic®: Automated Stool Management Kit
The Qoramatic is an intelligent, proactive fecal diversion system designed to reduce patient injury and incontinence-related complications, saving time and money. The Qoramatic prioritizes both patient and caregiver needs. Its indwelling receptacle eliminates the sensation of fullness, significantly improving comfort for patients. With fewer instances of fecal leakage, hospitals can enhance clinical outcomes, free up nursing resources, and focus on other critical patient care tasks.
The Qoramatic Features And Benefits:
• Automated Flushing: Keeps the receptacle and tubing clean, preventing blockages and odors.
• LED Indicators: Provide at-a-glance updates, simplifying operation and enhancing efficiency.
• Closed System Design: Minimizes risks of hospital-acquired infections (HAIs), skin breakdown, and cross-contamination.
For more information about the Qoramatic and to request a demonstration, call 888-891-1200 or email us to be connected to your local sales representative.
MED Alliance Group is a medical device distributor that has been dedicated to meeting the needs of our clinical customers and manufacturing partners since 1998. We specialize in the sales, marketing, importation, logistics and distribution of innovative, high-quality and cost-effective products found in anesthesia and respiratory, blood and transfusion therapy, EMS and emergency room, interventional radiology and cath lab, iv and vascular, as well as NICU and PICU.
Please follow us on LinkedIn, Facebook and Twitter for MED Alliance product updates.
References
1. “Fecal Incontinence.” Convatec Flexi-SealTM | Leading-edge Fecal Management Solutions, 21 Mar. 2023, flexi-seal.convatec.com/en/about-us/news-and-events/fecal-incontinence.
2. Park, Kyung Hee, and Heejung Choi. “Prospective Study on Incontinence-Associated Dermatitis and Its Severity Instrument for Verifying Its Ability to Predict the Development of Pressure Ulcers in Patients With Fecal Incontinence.” International Wound Journal, vol. 13, no. S1, Feb. 2016, pp. 20–25. https://doi.org/10.1111/iwj.12549.
3. Zhang, Shanshan, et al. “Cost of Hospital Management of Clostridium Difficile Infection in United States—a Meta-analysis and Modelling Study.” BMC Infectious Diseases, vol. 16, no. 1, Aug. 2016, https://doi.org/10.1186/s12879-016-1786-6.